Caribou Biosciences, Inc. (CRBU)
Caribou Biosciences, Inc. (CRBU) Insider Trading
Directors, officers and holders of more than 10% of CRBU report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 50 transactions on file: 2 with code P, 8 with code S and 40 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 25, 2026 | Kelly Timothy P | Chief Technology Officer | S Sale | 6,228 | $1.93 | $12,020 |
| Feb 24, 2026 | MCCLUNG BARBARA G | Chief Legal Officer | S Sale | 6,938 | $1.96 | $13,598 |
| Feb 24, 2026 | Khan Ruhi Ahmad | Chief Business Officer | S Sale | 6,938 | $1.96 | $13,598 |
| Feb 24, 2026 | Kelly Timothy P | Chief Technology Officer | S Sale | 3,147 | $1.96 | $6,168 |
| Feb 24, 2026 | Albertson Tina M. | Chief Medical Officer | S Sale | 1,066 | $1.96 | $2,089 |
| Feb 20, 2026 | Haurwitz Rachel E. | President and CEO | A Award | 682,500 | Not measured | Not measured |
| Feb 20, 2026 | Kelly Timothy P | Chief Technology Officer | A Award | 202,500 | Not measured | Not measured |
| Feb 20, 2026 | MCCLUNG BARBARA G | Chief Legal Officer | A Award | 202,500 | Not measured | Not measured |
| Feb 20, 2026 | Albertson Tina M. | Chief Medical Officer | A Award | 55,000 | Not measured | Not measured |
| Feb 20, 2026 | Albertson Tina M. | Chief Medical Officer | A Award | 247,500 | Not measured | Not measured |
| Feb 20, 2026 | Khan Ruhi Ahmad | Chief Business Officer | A Award | 202,500 | Not measured | Not measured |
| Feb 20, 2026 | Ryali Sriram | Chief Financial Officer | A Award | 55,000 | Not measured | Not measured |
| Feb 20, 2026 | Haurwitz Rachel E. | President and CEO | A Award | 151,700 | Not measured | Not measured |
| Feb 20, 2026 | Kelly Timothy P | Chief Technology Officer | A Award | 45,000 | Not measured | Not measured |
| Feb 20, 2026 | Whiting Nancy | Director | A Award | 45,000 | Not measured | Not measured |
| Feb 20, 2026 | JOHNSON DAVID LEE | Director | A Award | 45,000 | Not measured | Not measured |
| Feb 20, 2026 | GUGGENHIME ANDREW | Director | A Award | 45,000 | Not measured | Not measured |
| Feb 20, 2026 | Braunstein Scott | Director | A Award | 45,000 | Not measured | Not measured |
| Feb 20, 2026 | Ryali Sriram | Chief Financial Officer | A Award | 247,500 | Not measured | Not measured |
| Feb 20, 2026 | Khan Ruhi Ahmad | Chief Business Officer | A Award | 45,000 | Not measured | Not measured |
| Feb 20, 2026 | Sacks Natalie | Director | A Award | 45,000 | Not measured | Not measured |
| Feb 20, 2026 | Richardson-Heron Dara | Director | A Award | 45,000 | Not measured | Not measured |
| Feb 20, 2026 | Zheng Ran | Director | A Award | 45,000 | Not measured | Not measured |
| Feb 20, 2026 | MCCLUNG BARBARA G | Chief Legal Officer | A Award | 45,000 | Not measured | Not measured |
| Mar 14, 2025 | Haurwitz Rachel E. | President and CEO | P Purchase | 20,000 | $1.02 | $20,400 |
| Feb 21, 2025 | Khan Ruhi Ahmad | Chief Business Officer | S Sale | 3,564 | $1.35 | $4,811 |
| Feb 21, 2025 | MCCLUNG BARBARA G | Chief Legal Officer | S Sale | 3,564 | $1.35 | $4,811 |
| Feb 21, 2025 | Kanner Steven | Chief Scientific Officer | S Sale | 3,564 | $1.35 | $4,811 |
| Feb 20, 2025 | GUGGENHIME ANDREW | Director | A Award | 40,500 | Not measured | Not measured |
| Feb 20, 2025 | Albertson Tina M. | Chief Medical Officer | A Award | 14,589 | Not measured | Not measured |
| Feb 20, 2025 | MCCLUNG BARBARA G | Chief Legal Officer | A Award | 37,500 | Not measured | Not measured |
| Feb 20, 2025 | Khan Ruhi Ahmad | Chief Business Officer | A Award | 37,500 | Not measured | Not measured |
| Feb 20, 2025 | Kelly Timothy P | Chief Technology Officer | A Award | 37,500 | Not measured | Not measured |
| Feb 20, 2025 | Kanner Steven | Chief Scientific Officer | A Award | 37,500 | Not measured | Not measured |
| Feb 20, 2025 | Haurwitz Rachel E. | President and CEO | A Award | 618,250 | Not measured | Not measured |
| Feb 20, 2025 | Zheng Ran | Director | A Award | 40,500 | Not measured | Not measured |
| Feb 20, 2025 | Richardson-Heron Dara | Director | A Award | 40,500 | Not measured | Not measured |
| Feb 20, 2025 | JOHNSON DAVID LEE | Director | A Award | 40,500 | Not measured | Not measured |
| Feb 20, 2025 | Haurwitz Rachel E. | President and CEO | A Award | 136,750 | Not measured | Not measured |
| Feb 20, 2025 | Albertson Tina M. | Chief Medical Officer | A Award | 66,137 | Not measured | Not measured |
| Feb 20, 2025 | Braunstein Scott | Director | A Award | 40,500 | Not measured | Not measured |
| Feb 20, 2025 | MCCLUNG BARBARA G | Chief Legal Officer | A Award | 170,000 | Not measured | Not measured |
| Feb 20, 2025 | Khan Ruhi Ahmad | Chief Business Officer | A Award | 170,000 | Not measured | Not measured |
| Feb 20, 2025 | Kelly Timothy P | Chief Technology Officer | A Award | 170,000 | Not measured | Not measured |
| Feb 20, 2025 | Kanner Steven | Chief Scientific Officer | A Award | 170,000 | Not measured | Not measured |
| Feb 20, 2025 | Whiting Nancy | Director | A Award | 40,500 | Not measured | Not measured |
| Feb 20, 2025 | Sacks Natalie | Director | A Award | 40,500 | Not measured | Not measured |
| Jan 29, 2025 | Ryali Sriram | Chief Financial Officer | P Purchase | 17,360 | $1.42 | $24,651 |
| Jan 10, 2025 | Ryali Sriram | Chief Financial Officer | A Award | 300,000 | Not measured | Not measured |
| Nov 20, 2024 | Fischesser Ryan | VP of Finance and Controller | A Award | 25,000 | Not measured | Not measured |
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.